MedTrace Logo

Effects of Exercise Intervention on Aging-related Motor Decline

NCT01787292 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2020-02-20

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to test whether differing levels of physical fitness affects patterns of motor dexterity and brain activity that have been shown to differ due to aging. Testing will take place at the Atlanta VA Medical Center and at Emory University.

Participants will be healthy adults within the target age range of 60-85 for the study. The study will require multiple visits over 15 months. There will be about 64 people volunteering for this study.

Conditions

  • Aging
  • Exercise

Interventions

BEHAVIORAL

Stretching Exercise Intervention

A. Light stretching and balance exercises under supervised trainer. 3 times per week for 20-45 minutes. HR will be targeted to be under 50% of age-related maximum.

BEHAVIORAL

Aerobic Exercise Intervention

Supervised weekly exercise. 3 bouts of 45 minutes weekly on a cycle ergometer. HR will be kept at 75% of age-related maximum.

BEHAVIORAL

Self Monitoring

6 month self-monitored training phase during which time participants will exercise according to prescribed regimen (cycling)

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Keith M. McGregor, PhD MS BA · Atlanta VA Medical and Rehab Center, Decatur, GA

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-14
Primary Completion
2018-07-07
Completion
2019-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01787292 on ClinicalTrials.gov